News|Articles|February 10, 2023
SCOPE 2023: Challenging Operational Aspects of Clinical Trials
Author(s)Lisa Henderson
Len Rosenberg, head of clinical operations at Beat AML, reveals how changing the backbone treatment to a different regimen is beneficial to the patient, in terms of the safety with the same efficacy.
Advertisement
In an interview at the 2023 SCOPE conference with ACT Editor-in-Chief, Lisa Henderson, Len Rosenberg, head of clinical operations at Beat AML, explains the operational obstacles that come with clinical trials, including background treatment dosages.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Reaffirms GCP Standards Amid Growing Concerns Over Foreign Clinical Trial Data
2
Beyond Patient Centricity: What Rare Disease Research Gets Right
3
Fortrea to Acquire Worldwide Clinical Trials' Early Phase Services Division in $45 Million Deal
4
AI Moves Patient Recruitment from Trial Bottleneck to Competitive Edge: A 2026 Perspective
5